FDA对卵巢癌的认可将焦点转向安捷伦估值与市场动能 - simplywall.st
FDA Ovarian Cancer Nod Puts Focus On Agilent Valuation And Momentum - simplywall.st
生命科学资讯
生物技术与制药领域的最新动态
安捷伦科技公司（NYSE:A）获分析师平均评级为“适度买入”——MarketBeat
Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
安捷伦获FDA批准用于卵巢癌伴随诊断 - Femtech Insider
Agilent Receives FDA Approval for Companion Diagnostic in Ovarian Cancer - Femtech Insider
安捷伦伴随诊断获FDA批准，与Keytruda最新癌症适应症同步获批。
Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval
安捷伦科技公司（NYSE:A）宣布派发每股0.26美元季度股息——MarketBeat报道
Agilent Technologies, Inc. (NYSE:A) to Issue $0.26 Quarterly Dividend - MarketBeat
Agilent伴随诊断获FDA批准，与Keytruda最新癌症疗法同步获批——Fierce Biotech报道
Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval - Fierce Biotech
安捷伦宣布每股派发现金股息25.5美分 - 01net
Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net
安捷伦科技(A)宣布季度股息0.255美元，收益率0.8% - StreetInsider报道
Agilent Technologies (A) Declares $0.255 Quarterly Dividend; 0.8% Yield - StreetInsider
安捷伦宣布每股派发现金股息25.5美分 - 雅虎财经
Agilent Announces Cash Dividend of 25.5 Cents per Share - Yahoo Finance
持有安捷伦股票至3月31日？4月将获0.255美元现金分红——股票泰坦
Own Agilent stock by March 31? A $0.255 cash payout is coming in April - Stock Titan
安捷伦授予勃林格殷格翰首届2025仪器以旧换新影响力奖 - BioSpace
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - BioSpace
FDA批准推动安捷伦科技（A）诊断工具发展 - GuruFocus
FDA Approval Boosts Agilent Technologies (A) Diagnostic Tool - GuruFocus
安捷伦授予勃林格殷格翰首届2025仪器以旧换新影响力奖 - 商业资讯
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - Business Wire
麦迪逊资产管理有限责任公司出售14,089股安捷伦科技公司股票 $A - MarketBeat
Madison Asset Management LLC Sells 14,089 Shares of Agilent Technologies, Inc. $A - MarketBeat
安捷伦获得FDA批准，PD-L1 IHC 22C3 pharmDx用于上皮性卵巢癌、输卵管癌或原发性腹膜癌（EOC）检测——商业通讯社
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC) - Business Wire
FDA批准首个免疫疗法相关检测指导卵巢癌治疗 - 股票泰坦
FDA approves first immunotherapy-linked test to guide ovarian cancer care - Stock Titan
气相色谱检测器市场即将迎来繁荣 |• 安捷伦科技 • 赛默飞世尔科技 - openPR.com
Gas Chromatography Detector Market Is Going to Boom |• Agilent Technologies • Thermo Fisher Scientific - openPR.com
安捷伦科技公司$A股份遭Impax资产管理集团减持 - MarketBeat
Agilent Technologies, Inc. $A Position Cut by Impax Asset Management Group plc - MarketBeat
计算安捷伦科技公司（纽约证券交易所代码：A）的公允价值 - 雅虎财经
Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A) - Yahoo Finance
Candriam S.C.A.增持安捷伦科技股份 $A - MarketBeat
Candriam S.C.A. Increases Holdings in Agilent Technologies, Inc. $A - MarketBeat